V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
R
RGNXAI Stock Diagnostic Report

REGENXBIO sinks as FDA puts RGX-121 gene therapy on clinical hold

REGENXBIO's stock price has declined following the FDA's clinical hold on the RGX-121 gene therapy.

View Source Article ↗
AI CATALYST SCORE45 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

RGNX Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-24 11:50:04RGNX45RowView Report →
2026-08-06 21:19:36RGNX75MidView Report →
2026-08-06 11:27:35RGNX85S-ClassView Report →
View Full History for RGNX (Blueprint) →